DAY 1 | Friday, June 23rd, 2023 | |
08.00-08.15 | Arrival-Registration | |
08.15-08.23 | Welcome Introduction | |
Moderators: D. Karnabatidis (GR), K. Katsanos (GR), P. Kitrou (GR) | ||
08.24-09.09 | What is New and Interesting in Vascular Access | |
Moderators: D. Karnabatidis (GR), P. Kitrou (GR) | ||
The Nephrologist’s view | H. Wasse (USA) | |
The Vascular Surgeon’s view | R. Shahverdyan (DE) | |
The Interventional Radiologist’s View | J.M. Abadal (SP) | |
Unmet Needs | A. Kamel (USA) | |
Discussion | ||
Panel: K. Katsanos (GR), C. Lok (CA), N. Karydis (GR) | ||
09.10-10.10 | Trial Updates | |
Moderators: K. Katsanos (GR), P. Kitrou (GR) | ||
The FAME Study | I. Giannikouris (GR) | |
The ABISS trial | R. Coscas (FR)* | |
The WRAP Registry | D. Rajan (CA) | |
LTX Global AV. The AVF Cohort | D. Karnabatidis (GR) | |
aXess-FIH Clinical Study | M. Tozzi (IT) | |
Single-Center Experience of the Inside-Out Technique for Central Venous Stenosis | G. Sengoelge (AU) | |
Results From the Use of a New Covered Stent for the Treatment of Vascular Access | L. Harduin (BR) | |
The SAVE trial | K. Katsanos (GR) | |
Discussion | ||
10.11-10.41 | Company Symposium | |
10.42-11.27 | The Patient in Kidney Replacement Therapy | |
Moderators: H. Wasse (USA), P. Kitrou (GR) | ||
AVACS: A New Measure for Vascular Access | C. Lok (CA) | |
Patient’s Perspective | V. Papageorgiou (GR) | |
Patient’s Perspective | P. West (UK) | |
Discussion | ||
Panel: N. Karydis (GR), N. Inston (UK), G. Sengoelge (AU) | ||
11.28-11.48 | Coffee Break | |
11.49-12.25 | Home Dialysis | |
Moderators: E. Papachristou (GR), S. Balamuthusamy (USA) | ||
Dialysis at Home. Global Overview and Financial Considerations | G. Sengoelge (AU) | |
Home Dialysis is the Future | M. Aragon (USA) | |
Home Dialysis Will Never be Established | M. Gallieni (IT) | |
Discussion | ||
Panel: H. Wasse (USA), J. Ibeas (SP), C. Lok (CA) | ||
12.26-12.56 | Company Symposium | |
12.57-13.57 | Percutaneous AVF Creation | |
Moderators: P. Kitrou (GR), C. Lok (CA) | ||
Where do we stand? | N. Inston (UK) | |
More patients are eligible for a Thermal-based AVF | R. Shahverdyan (DE) | |
More patients are eligible for a RF-based AVF | D. Rajan (CA) | |
Secondary Interventions Case Sharing in Thermal-based AVFs | J. Hull (USA) | |
Secondary Interventions Case Sharing in RF-based AVFs | T. Steinke (DE) | |
I Would Still Prefer a Gracz Fistula | F. Gryffroy (BE) | |
Discussion | ||
Panel: Y. Al Zahrani (KSA), G. Falcone (IT), L. Novosel (CR) | ||
13.58-14.38 | Lunch Break | |
14.39-15.09 | Congreso GEMAV @ EVA | |
Moderators: J. Ibeas (SP) | ||
Artificial Intellingence and VA | J. Ibeas (SP) | |
Discussion | ||
15.10-15.40 | The “Spotlight” | |
Moderators: D. Karnabatidis (GR), K. Katsanos (GR), S. Spiliopoulos (GR)*, P. Kitrou (GR) | ||
DELPHI Consensus on Volume Flow Measurements in Vascular Access | ||
15.41-16.26 | Vascular Access Thrombosis | |
Moderators: Z. Haskal (USA), D. Rajan (CA) | ||
Established Debulking Devices | L. Novosel (CR) | |
Devices Used in Other Vascular Beds. Can they Provide a Solution? | O. Jaffer(UK) | |
Declotting Mega Fistulas | M. Tozzi (IT) | |
Radial Access. Is it better? | A. Farkas (IL) | |
Antiplatelets and Anticoagulants During and After Thrombectomy. Do they play a role? | E. Kehagias (GR) | |
Discussion | ||
Panel: P. Kitrou (GR), A. Kamel (USA), L Harduin (BR) | ||
16.27-16.57 | Company Symposium | |
16.58-17.48 | Ultrasound in Vascular Access | |
Moderators: E. Konstantatou (GR), N. Karunanithy (UK) | ||
Surgical and Percutaneous AVF Screening | O. Jaffer (UK) | |
US Assessment of Stenotic Types and US-guided Endovascular Procedures | J.M. Abadal (SP) | |
Volume Flow. Is This the Ultimate Tool? | S. Spiliopoulos (GR)* | |
POCUS in Nephrology | G. Georgopoulou (GR) | |
Discussion | ||
Panel: K. Katsanos (GR), S. Balamuthusamy (USA), J. Ibeas (SP) | ||
17.49-18.49 | Editor Writing Club by Ziv Haskal (USA) | |
DAY 2 | Saturday, June 24th, 2023 | |
08.00-09.15 | Morbidity & Mortality Cases in Vascular Access | |
Moderators: D. Karnabatidis (GR), P. Kitrou (GR) | ||
A not so Routine Superior Vena Cava Angioplasty | D. Rajan (CA) | |
Central Venous Catheter Exchange. What Can Go Wrong? | M. Theofanis (GR) | |
A Series of Unfortunate Events | B. Dolmatch (USA) | |
Remember the Basics | O. Jaffer (UK) | |
Loss of Situational Awareness: Graft Thrombectomy | Z. Haskal (USA) | |
Discussion | ||
Panel: J. Ho Pei (SG), K. Katsanos (GR), J.M. Abadal (SP) | ||
09.16-10.16 | The Way Ahead | |
Moderators: O. Jaffer (UK), N. Inston (UK) | ||
New Generation Grafts for Vascular Access | H. Wasse (USA) | |
Endovascular Devices in Vascular Access | S. Balamuthusamy (USA) | |
New Devices in Percutaneous Arteriovenous Fistula Creation | R. Shahverdyan (DE) | |
Next Generation Stents | B. Dolmatch (USA) | |
Drug Therapies in Vascular Access | M. Papasotiriou (GR) | |
Augmented and Virtual Reality in Vascular Access | J. Ibeas (SP) | |
Artificial Intelligence and Robotics in Endovascular Procedures | M. Krokidis (GR) | |
Discussion | ||
Panel: A. Kamel (USA), K. Moulakakis (GR), E. Papachristou (GR) | ||
10.17-10.47 | Company Symposium | |
10.48-11.18 | SAVE @ EVA | |
Moderator: B. Dolmatch (USA) | ||
The Brazilian Multicenter Experience with a Cell Impermeable Covered Stent | T. Baroso (BR) | |
The Outflow Challenging Reconstruction | L. Cortizo (BR) | |
Oversized Balloon-Assisted Maturation Technique | L. Harduin (BR) | |
Discussion | ||
11.19-11.39 | Coffee Break | |
11.40-12.30 | The Cardiovascular Implications of Hemodialysis Vascular Access | |
Moderators: Papasotiriou (GR), C. Lok (CA) | ||
The Effects of Vascular Access in Blood Pressure | G. Sengoelge (AU) | |
The Pathology and Pathophysiology of the Effects of Vascular Access to the Heart | A. Athanasiou (GR) | |
Hand Ischemia and Steal Syndrome | K. Moulakakis (GR) | |
Discussion | ||
Panel: N. Inston (UK), N. Karydis (GR), M. Gallieni (IT) | ||
12.31-13.01 | Company Symposium | |
13.02-13.37 | Guidelines Updates and Initiatives on Vascular Access Treatment | |
Moderators: D. Goumenos (GR), K. Katsanos (GR) | ||
Vascular Access Guidelines. Global Considerations | C. Lok (CA) | |
UK Kidney Association Guidelines | N. Karunanithy (UK) | |
Code: “Fistula” | J. Ibeas (SP) | |
Commentary | M. Gallieni (IT) | |
Discussion | ||
Panel: H. Wasse (USA), G. Bamichas (GR), D. Petras (GR) | ||
13.38-14.18 | Lunch Break | |
14.19-14.49 | Amazing Interventions | |
Moderators: D. Karnabatidis (GR), K. Katsanos (GR) | ||
Amazing Result of Far from Amazing Percutaneous Arteriovenous Fistula | L. Tkalcic (CR) | |
Access Salvage: Persist, Insist and Dare | P. Filippou | |
Percutaneous Arteriovenous Fistula for Deep Venous Arterialization | J. Hull (USA) | |
Percutaneous Arteriovenous Fistula rescue for Venous Hypertension | G. Gabbani (IT) | |
The Unfortunate Impact of Cardiology on Dialysis Patient’s Life-Plan | F. Gryffroy (BE) | |
Discussion | ||
14.50-15.40 | Central Venous Stenosis and Occlusion | |
Moderators: B. Dolmatch (USA), D. Karnabatidis (GR) | ||
Histopathologic and Hemodynamic Background of Central Venous Disease | J. Ho Pei (SG) | |
Catheter-Related Central Venous Implications | G. Bamichas (GR) | |
Crossing the Lesion | J. Ho Pei (SG) | |
Intravascular Ultrasound as a Tool for Central Venous Stenosis. | A. Justaniah (KSA) | |
Treatment Options in the Spotlight | P. Kitrou (GR) | |
Don’t Treat it! | T. Steinke (DE) | |
Discussion | ||
Panel: D. Rajan (CA), J. Hull (CA), J.M. Abadal (SP) | ||
15.41-16.11 | SIRS @ EVA | |
Moderator: A. Justaniah (KSA) | ||
Central Venous Recanalization: Stent or no Stent | A. Justaniah (KSA) | |
Central venous angioplasty in patients with cardiac implantable devices | Y. Al Zahrani (KSA) | |
Interventional Radiology in Saudi Arabia | A. Justaniah (KSA) | |
Discussion | ||
16.12-16.52 | The Financial Reality of Vascular Access Management | |
Moderators: P. Kitrou (GR), J.M. Abadal (SP) | ||
Medical Device Regulation in the European Union and its Financial Repercussions | K. Kolasa (PL) | |
Machine Learning Analytics in Vascular Access. A Tool Towards Cost-Effectiveness? | S. Balamuthusamy (USA) | |
Financial Analysis of the Use of DCBs in Vascular Access | K. Katsanos (GR) | |
Cost-Analysis of Covered Stent Use in Vascular Access | B. Dolmatch (USA) | |
Discussion | ||
Panel: N. Karunanithy (UK), L. Novosel (CR), F. Gryffroy (BE) | ||
16.53-17.43 | Peritoneal Dialysis | |
Moderators: D. Petras (GR), J. Ibeas (SP) | ||
The Surgical Option | N. Karydis (GR) | |
The Percutaneous Option | Y. Al Zahrani (KSA) | |
Infections and Optimal Treatment | M. Marangos (GR) | |
Periprocedural Complications & Treatment | E. Papachristou (GR) | |
Long-Term Complications & Treatment | G. Georgopoulou (GR) | |
Panel: C. Lok (CA), G. Sengoelge (AU), H. Wasse (USA) | ||
17.44-18.44 | Editor Writing Club by Ziv Haskal (USA) |
FILES